Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07354308 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Efficacy of an Avocado Dietary Supplement
A NA study of Overweight and Insulin Resistance, sponsored by SP Nutraceuticals.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07354308: Active NA study of Overweight and Insulin Resistance, sponsored by SP Nutraceuticals.
NCT07354308 is a NA study of Overweight and Insulin Resistance that is active but no longer recruiting, run by SP Nutraceuticals. The registered enrollment target is 60 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07354308, a NA study of Overweight and Insulin Resistance, is active but no longer recruiting, sponsored by SP Nutraceuticals.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This 16-week, randomized, triple-blinded, placebo-controlled study evaluates the effects of an avocado dietary supplement (Metavo) on healthy weight and blood glucose management in overweight adults. The study includes body measurements, questionnaires, blood tests, and CGM monitoring to assess metabolic outcomes and participant-reported perceptions of well-being.
Primary Outcome
Measured via Withings Smart Scale. Participants will weigh themselves daily for 3 consecutive days each week. If the first two values are similar, their average is used. If they differ by ≥10 lbs, the third value is used to determine the average.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Metavo Supplement
Study Locations (1)
Nevada
- Citruslabs - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-01 |
| Phase | NA |
What the registry record for NCT07354308 still lists
NCT07354308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07354308 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT07354308 about?
NCT07354308 is a clinical study titled "Study to Evaluate the Efficacy of an Avocado Dietary Supplement". This 16-week, randomized, triple-blinded, placebo-controlled study evaluates the effects of an avocado dietary supplement (Metavo) on healthy weight and blood glucose management in overweight adults. The study includes body measurements, questionnaires, blood tests, and CGM monitoring to assess meta...
What is the current status of trial NCT07354308?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-01. Estimated completion is 2026-01.
What conditions does trial NCT07354308 study?
This clinical trial studies the following conditions: Overweight, Insulin Resistance, Metabolic Health.
What interventions are being tested in trial NCT07354308?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Metavo Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07354308?
This trial is sponsored by SP Nutraceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07354308 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07354308's enrollment target sits among peer trials
60 138th of 197 higher than 54 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
RECRUITING · NA
-
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
RECRUITING · NA
-
The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI